annual FCF:
$214.29M+$89.82M(+72.16%)Summary
- As of today (May 24, 2025), AMED annual free cash flow is $214.29 million, with the most recent change of +$89.82 million (+72.16%) on December 31, 2024.
- During the last 3 years, AMED annual FCF has risen by +$32.12 million (+17.63%).
- AMED annual FCF is now -24.44% below its all-time high of $283.62 million, reached on December 31, 2020.
Performance
AMED Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
-$5.10M-$74.07M(-107.40%)Summary
- As of today (May 24, 2025), AMED quarterly free cash flow is -$5.10 million, with the most recent change of -$74.07 million (-107.40%) on March 31, 2025.
- Over the past year, AMED quarterly FCF has increased by +$4.33 million (+45.91%).
- AMED quarterly FCF is now -103.82% below its all-time high of $133.66 million, reached on June 30, 2020.
Performance
AMED quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$218.62M+$4.33M(+2.02%)Summary
- As of today (May 24, 2025), AMED TTM free cash flow is $218.62 million, with the most recent change of +$4.33 million (+2.02%) on March 31, 2025.
- Over the past year, AMED TTM FCF has increased by +$127.98 million (+141.20%).
- AMED TTM FCF is now -34.03% below its all-time high of $331.40 million, reached on March 31, 2021.
Performance
AMED TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
AMED Free cash flow Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +72.2% | +45.9% | +141.2% |
3 y3 years | +17.6% | -110.8% | +23.3% |
5 y5 years | +10.4% | -210.9% | +21.6% |
AMED Free cash flow Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +72.2% | -104.9% | +67.0% | at high | +147.1% |
5 y | 5-year | -24.4% | +72.2% | -103.8% | +67.0% | -34.0% | +147.1% |
alltime | all time | -24.4% | +376.4% | -103.8% | +94.5% | -34.0% | +341.9% |
AMED Free cash flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2025 | - | -$5.10M(-107.4%) | $218.62M(+2.0%) |
Dec 2024 | $214.29M(+72.2%) | $68.96M(-33.7%) | $214.29M(+5.3%) |
Sep 2024 | - | $104.03M(+105.0%) | $203.54M(+130.1%) |
Jun 2024 | - | $50.73M(-637.8%) | $88.47M(-2.4%) |
Mar 2024 | - | -$9.43M(-116.2%) | $90.64M(-27.2%) |
Dec 2023 | $124.47M(-1.3%) | $58.21M(-627.2%) | $124.47M(+18.4%) |
Sep 2023 | - | -$11.04M(-120.9%) | $105.12M(+4.4%) |
Jun 2023 | - | $52.91M(+116.8%) | $100.69M(-2.2%) |
Mar 2023 | - | $24.40M(-37.2%) | $102.99M(-18.3%) |
Dec 2022 | $126.07M(-30.8%) | $38.85M(-351.1%) | $126.07M(+38.5%) |
Sep 2022 | - | -$15.47M(-128.0%) | $90.99M(-45.1%) |
Jun 2022 | - | $55.21M(+16.3%) | $165.84M(-6.4%) |
Mar 2022 | - | $47.48M(+1156.5%) | $177.27M(-2.7%) |
Dec 2021 | $182.17M(-35.8%) | $3.78M(-93.6%) | $182.17M(-24.7%) |
Sep 2021 | - | $59.38M(-10.9%) | $241.97M(-8.5%) |
Jun 2021 | - | $66.63M(+27.2%) | $264.38M(-20.2%) |
Mar 2021 | - | $52.38M(-17.6%) | $331.40M(+16.8%) |
Dec 2020 | $283.62M(+46.1%) | $63.58M(-22.3%) | $283.62M(-3.4%) |
Sep 2020 | - | $81.79M(-38.8%) | $293.71M(+14.9%) |
Jun 2020 | - | $133.66M(+2804.9%) | $255.74M(+42.2%) |
Mar 2020 | - | $4.60M(-93.8%) | $179.85M(-7.3%) |
Dec 2019 | $194.11M(-10.5%) | $73.67M(+68.2%) | $194.11M(+5.7%) |
Sep 2019 | - | $43.81M(-24.2%) | $183.60M(-10.1%) |
Jun 2019 | - | $57.77M(+206.3%) | $204.20M(+3.7%) |
Mar 2019 | - | $18.86M(-70.1%) | $196.93M(-9.2%) |
Dec 2018 | $216.93M(+128.3%) | $63.16M(-1.9%) | $216.93M(+17.7%) |
Sep 2018 | - | $64.41M(+27.5%) | $184.32M(+43.5%) |
Jun 2018 | - | $50.50M(+30.0%) | $128.49M(+15.6%) |
Mar 2018 | - | $38.85M(+27.2%) | $111.17M(+17.0%) |
Dec 2017 | $95.02M(+104.2%) | $30.56M(+256.3%) | $95.02M(+4.6%) |
Sep 2017 | - | $8.58M(-74.2%) | $90.81M(+6.3%) |
Jun 2017 | - | $33.18M(+46.1%) | $85.45M(+34.1%) |
Mar 2017 | - | $22.71M(-13.8%) | $63.71M(+36.9%) |
Dec 2016 | $46.54M(-46.1%) | $26.35M(+719.2%) | $46.54M(+26.5%) |
Sep 2016 | - | $3.22M(-71.9%) | $36.78M(-41.6%) |
Jun 2016 | - | $11.44M(+106.4%) | $62.97M(-20.8%) |
Mar 2016 | - | $5.54M(-66.6%) | $79.53M(-7.9%) |
Dec 2015 | $86.36M(-211.4%) | $16.58M(-43.6%) | $86.36M(+19.5%) |
Sep 2015 | - | $29.40M(+5.0%) | $72.24M(+7.2%) |
Jun 2015 | - | $28.00M(+126.3%) | $67.37M(-226.4%) |
Mar 2015 | - | $12.37M(+401.0%) | -$53.30M(-31.3%) |
Dec 2014 | -$77.54M(-228.1%) | $2.47M(-89.9%) | -$77.54M(-8.1%) |
Sep 2014 | - | $24.53M(-126.5%) | -$84.36M(-6.7%) |
Jun 2014 | - | -$92.67M(+680.4%) | -$90.39M(-443.6%) |
Mar 2014 | - | -$11.87M(+172.8%) | $26.31M(-56.5%) |
Dec 2013 | $60.53M(+185.1%) | -$4.35M(-123.5%) | $60.53M(-6.1%) |
Sep 2013 | - | $18.50M(-23.1%) | $64.44M(+15.6%) |
Jun 2013 | - | $24.04M(+7.6%) | $55.75M(+30.0%) |
Mar 2013 | - | $22.34M(-5224.3%) | $42.88M(+102.0%) |
Dec 2012 | $21.23M(-78.1%) | -$436.00K(-104.4%) | $21.23M(-59.7%) |
Sep 2012 | - | $9.80M(-12.3%) | $52.74M(-9.3%) |
Jun 2012 | - | $11.17M(+1516.9%) | $58.18M(-5.4%) |
Mar 2012 | - | $691.00K(-97.8%) | $61.51M(-36.5%) |
Dec 2011 | $96.80M(-30.8%) | $31.07M(+103.9%) | $96.80M(+32.7%) |
Sep 2011 | - | $15.24M(+5.0%) | $72.95M(-20.1%) |
Jun 2011 | - | $14.51M(-59.7%) | $91.26M(-22.1%) |
Mar 2011 | - | $35.97M(+397.6%) | $117.21M(-16.2%) |
Dec 2010 | $139.93M(-32.1%) | $7.23M(-78.5%) | $139.93M(-7.4%) |
Sep 2010 | - | $33.55M(-17.1%) | $151.07M(-22.6%) |
Jun 2010 | - | $40.45M(-31.1%) | $195.21M(-10.4%) |
Mar 2010 | - | $58.69M(+219.4%) | $217.77M(+5.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2009 | $206.09M(+75.2%) | $18.38M(-76.3%) | $206.09M(-13.8%) |
Sep 2009 | - | $77.68M(+23.3%) | $239.11M(+31.6%) |
Jun 2009 | - | $63.02M(+34.1%) | $181.74M(+26.0%) |
Mar 2009 | - | $47.01M(-8.6%) | $144.25M(+22.6%) |
Dec 2008 | $117.63M(+82.5%) | $51.40M(+153.1%) | $117.63M(+63.4%) |
Sep 2008 | - | $20.31M(-20.5%) | $72.00M(+0.6%) |
Jun 2008 | - | $25.53M(+25.3%) | $71.56M(+25.5%) |
Mar 2008 | - | $20.38M(+252.8%) | $57.03M(-11.5%) |
Dec 2007 | $64.45M(+366.7%) | $5.78M(-70.9%) | $64.45M(-3.1%) |
Sep 2007 | - | $19.87M(+80.6%) | $66.52M(+31.9%) |
Jun 2007 | - | $11.00M(-60.4%) | $50.42M(-4.5%) |
Mar 2007 | - | $27.81M(+254.7%) | $52.79M(+282.3%) |
Dec 2006 | $13.81M(-40.3%) | $7.84M(+108.0%) | $13.81M(-11.3%) |
Sep 2006 | - | $3.77M(-71.8%) | $15.56M(-34.2%) |
Jun 2006 | - | $13.38M(-219.7%) | $23.64M(+244.5%) |
Mar 2006 | - | -$11.18M(-216.5%) | $6.86M(-70.4%) |
Dec 2005 | $23.15M(-5.4%) | $9.59M(-19.1%) | $23.15M(+35.9%) |
Sep 2005 | - | $11.85M(-447.9%) | $17.03M(+46.3%) |
Jun 2005 | - | -$3.41M(-166.7%) | $11.64M(-42.2%) |
Mar 2005 | - | $5.11M(+46.9%) | $20.13M(-17.8%) |
Dec 2004 | $24.48M(+22.4%) | $3.48M(-46.1%) | $24.48M(-9.0%) |
Sep 2004 | - | $6.46M(+27.2%) | $26.89M(+16.8%) |
Jun 2004 | - | $5.08M(-46.3%) | $23.03M(-5.5%) |
Mar 2004 | - | $9.46M(+60.8%) | $24.38M(+21.9%) |
Dec 2003 | $20.00M(+67.4%) | $5.89M(+126.7%) | $20.00M(+35.1%) |
Sep 2003 | - | $2.60M(-59.6%) | $14.80M(+5.3%) |
Jun 2003 | - | $6.43M(+26.5%) | $14.06M(+32.7%) |
Mar 2003 | - | $5.08M(+639.1%) | $10.60M(-11.3%) |
Dec 2002 | $11.95M(-200.6%) | $688.00K(-63.0%) | $11.95M(+147.8%) |
Sep 2002 | - | $1.86M(-37.4%) | $4.82M(+664.2%) |
Jun 2002 | - | $2.97M(-53.9%) | $631.00K(-108.8%) |
Mar 2002 | - | $6.43M(-199.9%) | -$7.14M(-39.9%) |
Dec 2001 | -$11.88M(-280.6%) | -$6.44M(+176.0%) | -$11.88M(-534.5%) |
Sep 2001 | - | -$2.33M(-51.4%) | $2.73M(-29.6%) |
Jun 2001 | - | -$4.80M(-383.4%) | $3.89M(-42.5%) |
Mar 2001 | - | $1.69M(-79.3%) | $6.76M(+2.7%) |
Dec 2000 | $6.58M(-165.0%) | $8.17M(-792.0%) | $6.58M(-512.0%) |
Sep 2000 | - | -$1.18M(-38.7%) | -$1.60M(+284.6%) |
Jun 2000 | - | -$1.93M(-227.4%) | -$415.00K(-127.4%) |
Mar 2000 | - | $1.51M(-118.6%) | $1.51M(-112.3%) |
Dec 1999 | -$10.12M(+40.1%) | - | - |
Mar 1999 | - | -$8.13M(-227.6%) | -$12.26M(+69.7%) |
Dec 1998 | -$7.23M(+178.1%) | $6.37M(-199.6%) | -$7.23M(-55.7%) |
Sep 1998 | - | -$6.40M(+56.1%) | -$16.30M(+77.2%) |
Jun 1998 | - | -$4.10M(+32.3%) | -$9.20M(+84.0%) |
Mar 1998 | - | -$3.10M(+14.9%) | -$5.00M(+92.4%) |
Dec 1997 | -$2.60M(-33.4%) | -$2.70M(-485.4%) | -$2.60M(-13.4%) |
Sep 1997 | - | $700.00K(+600.0%) | -$3.00M(+57.9%) |
Jun 1997 | - | $100.00K(-114.3%) | -$1.90M(-42.4%) |
Mar 1997 | - | -$700.00K(-77.4%) | -$3.30M(-15.4%) |
Dec 1996 | -$3.90M(-425.0%) | -$3.10M(-272.2%) | -$3.90M(+160.0%) |
Sep 1996 | - | $1.80M(-238.5%) | -$1.50M(-28.6%) |
Jun 1996 | - | -$1.30M(0.0%) | -$2.10M(-1150.0%) |
Mar 1996 | - | -$1.30M(+85.7%) | $200.00K(-83.3%) |
Dec 1995 | $1.20M(-166.7%) | -$700.00K(-158.3%) | $1.20M(-36.8%) |
Sep 1995 | - | $1.20M(+20.0%) | $1.90M(+171.4%) |
Jun 1995 | - | $1.00M(-433.3%) | $700.00K(-275.0%) |
Mar 1995 | - | -$300.00K(+200.0%) | -$400.00K(-60.0%) |
Dec 1994 | -$1.80M(+260.0%) | - | - |
Jun 1994 | - | -$100.00K(-88.9%) | -$1.00M(+11.1%) |
Mar 1994 | - | -$900.00K | -$900.00K |
Dec 1993 | -$500.00K | - | - |
FAQ
- What is Amedisys annual free cash flow?
- What is the all time high annual FCF for Amedisys?
- What is Amedisys annual FCF year-on-year change?
- What is Amedisys quarterly free cash flow?
- What is the all time high quarterly FCF for Amedisys?
- What is Amedisys quarterly FCF year-on-year change?
- What is Amedisys TTM free cash flow?
- What is the all time high TTM FCF for Amedisys?
- What is Amedisys TTM FCF year-on-year change?
What is Amedisys annual free cash flow?
The current annual FCF of AMED is $214.29M
What is the all time high annual FCF for Amedisys?
Amedisys all-time high annual free cash flow is $283.62M
What is Amedisys annual FCF year-on-year change?
Over the past year, AMED annual free cash flow has changed by +$89.82M (+72.16%)
What is Amedisys quarterly free cash flow?
The current quarterly FCF of AMED is -$5.10M
What is the all time high quarterly FCF for Amedisys?
Amedisys all-time high quarterly free cash flow is $133.66M
What is Amedisys quarterly FCF year-on-year change?
Over the past year, AMED quarterly free cash flow has changed by +$4.33M (+45.91%)
What is Amedisys TTM free cash flow?
The current TTM FCF of AMED is $218.62M
What is the all time high TTM FCF for Amedisys?
Amedisys all-time high TTM free cash flow is $331.40M
What is Amedisys TTM FCF year-on-year change?
Over the past year, AMED TTM free cash flow has changed by +$127.98M (+141.20%)